Youth and fentanyl: What every family needs to know OHSU roundtable discussion raises alarm about potentially deadly impact on young people who unwittingly take counterfeit pills.
OHSU Doernbecher welcomes ‘Chief Cuddling Officer,’ expanding Hospital Facility Dog Program June 10, 2022
By kids, for kids: Presenting the 2022 Doernbecher Freestyle XVIII patient-designers By Lisa McMahan June 30, 2022 Celebrated partnership with Nike has raised nearly $31 million for children’s hospital.
COVID-19 fattens up our body’s cells to fuel its viral takeover By Tom Rickey, PNNL June 28, 2022 Compounds that cut off the flow of fatty fuel stop the virus from replicating in the lab, OHSU researchers find.
Something Every Family Needs to Know: Youth and Fentanyl By Erik Robinson June 27, 2022 MEDIA ALERT: Media invited to learn more about potentially deadly impacts on young people who unwittingly take counterfeit pills.
OHSU adopts tight budget to support vital missions June 24, 2022 Global issues affect university’s bottom line; budget priorities emphasize long-term stability.
COVID-19 vaccine now available for children younger than 5 By Franny White June 21, 2022 OHSU encourages vaccination for young children; both Moderna and Pfizer are safe and effective.
Vacuna contra el COVID-19 disponible para niños menores de 5 años By Franny White June 20, 2022 OHSU fomenta la vacunación de los niños pequeños; la vacuna de Moderna y de Pfizer son seguras y eficaces.
Help for Ukraine: OHSU members collect donations, volunteer to assist By Erik Robinson June 16, 2022 OHSU delivers thousand of pounds of basic essentials, medical supplies; some provide aid on the ground.
New treatment strategy aims to stop rare liver cancer By Joe Rojas-Burke June 15, 2022 OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver.
U.S. News & World Report: OHSU Doernbecher among the top children’s hospitals By Sara Hottman June 14, 2022 The annual report ranked OHSU Doernbecher best in Oregon, with high marks in the Pacific region and nation.
OHSU Doernbecher welcomes ‘Chief Cuddling Officer,’ expanding Hospital Facility Dog Program By Lisa McMahan June 10, 2022 Casey helps comfort OHSU’s smallest patients, families in the Neonatal Intensive Care, Labor and Delivery, and Mother-Baby units.
COVID-19 fattens up our body’s cells to fuel its viral takeover By Tom Rickey, PNNL June 28, 2022 Compounds that cut off the flow of fatty fuel stop the virus from replicating in the lab, OHSU researchers find.
Something Every Family Needs to Know: Youth and Fentanyl By Erik Robinson June 27, 2022 MEDIA ALERT: Media invited to learn more about potentially deadly impacts on young people who unwittingly take counterfeit pills.
OHSU adopts tight budget to support vital missions June 24, 2022 Global issues affect university’s bottom line; budget priorities emphasize long-term stability.
Booster dose and breakthrough infection provide similar COVID ‘super immunity,’ study finds By Erik Robinson April 20, 2022 OHSU laboratory research compares immune response to live virus variants, including omicron.
COVID-19 vaccine now available for children younger than 5 By Franny White June 21, 2022 OHSU encourages vaccination for young children; both Moderna and Pfizer are safe and effective.
Understanding the aggressive breast cancers missed by mammogram screening By Joe Rojas-Burke June 30, 2020 Research by OHSU, Oregon State University points to an aggressive form of breast cancer not detected readily by screening.
Monkeypox: OHSU expert advises vigilance, not alarm By Erik Robinson May 26, 2022 Immunologist Mark Slifka notes that monkeypox is a cousin to smallpox, does not spread like COVID-19.
By kids, for kids: Presenting the 2022 Doernbecher Freestyle XVIII patient-designers By Lisa McMahan June 30, 2022 Celebrated partnership with Nike has raised nearly $31 million for children’s hospital.
Vacuna contra el COVID-19 disponible para niños menores de 5 años By Franny White June 20, 2022 OHSU fomenta la vacunación de los niños pequeños; la vacuna de Moderna y de Pfizer son seguras y eficaces.
New treatment strategy aims to stop rare liver cancer By Joe Rojas-Burke June 15, 2022 OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver.